P0 · Therapeutic area intelligence
Infectious disease patent intelligence
Antiviral, antibacterial, and vaccine-related pharmaceutical patents.
- Patents
- 1,492
Quick answer
1,492 US pharmaceutical patents in our index match Infectious disease title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.
-
US 7303754
MVA expressing modified HIV envelope, gag, and pol genes
granted -
US 7288369
Replication competent hepatitis C virus and methods of use
granted -
US 7285383
Method for selective inactivation of viral replication
granted -
US 7282205
Anti-hepatitis A virus antibodies
granted -
US 7279306
Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus L1 proteins, and uses thereof
granted -
US 7276227
Obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity
granted -
US 7273851
Tri-peptide hepatitis C serine protease inhibitors
granted -
US 7268122
Use of oversulfated polysaccharides as inhibitors of HIV
granted -
US 7262027
Polypeptide and DNA immunization against Coccidioides spp. infections
granted -
US 7259167
Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds having increased solubility, and methods of making and using thereof
granted -
US 7253275
Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
granted -
US 7247307
Vaccines against Escherichia coli O157 infection
granted -
US 7244617
Diminishing viral gene expression by promoter replacement
granted -
US 7238800
Peptides and DNA encoding the peptides useful for immunizations against Coccidioides spp. infections
granted -
US 7235234
Bacterial delivery system
granted -
US 7235644
Vaccine against Gram-negative bacterial infections
granted -
US 7232566
Methods for treating HIV infected subjects
granted -
US 7227011
Nucleic acid vaccines for prevention of flavivirus infection
granted -
US 7223388
Modified reoviral therapy
granted -
US 7223787
Prenylation inhibitors reduce host cell permissiveness to viral replication
granted -
US 7223585
Viral purification methods
granted -
US 7220421
Moraxella bovis cytotoxin, cytotoxin gene, antibodies and vaccines for prevention and treatment of Moraxella bovis infections
granted -
US 7217541
Method of making CS6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic Escherichia coli infections
granted -
US 7201911
Cloned genomes of infectious hepatitis C viruses and uses thereof
granted -
US 7201902
Production of recombinant protein pap 31 for the diagnosis and prevention of Bartonella bacilliformis infection
granted -
US 7192593
Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
granted -
US 7183268
2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purine antiviral agents
granted -
US 7183095
Cell culture system for synthesis of infectious hepatitis C virus
granted -
US 7176208
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
granted -
US 7173007
Therapy for microbial infections
granted -
US 7157473
Pyridyl substituted heterocycles useful for treating or preventing HCV infection
granted -
US 7157495
Hexahydrofuro[2,3-B]furan-3-YL-N-{3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl}carbamate as retroviral protease inhibitor
granted -
US 7153880
Substituted diphenyl heterocycles useful for treating HCV infection
granted -
US 7151087
CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection
granted -
US 7148323
Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus
granted -
US 7144875
Methods of treating fungal infections using lupeol
granted -
US 7135324
Viral recombinases, related articles, and methods of use thereof
granted -
US 7132454
HEXIM1 as a suppressor of HIV replication and cardiac hypertrophy
granted -
US 7132271
Methods for enhancing the production of viral vaccines in cell culture
granted -
US 7132102
Bacteriocins and novel bacterial strains
granted -
US 7129342
Infectious cDNA clone of GB virus B and uses thereof
granted -
US 7125845
Aza-peptide macrocyclic hepatitis C serine protease inhibitors
granted -
US 7115590
Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents
granted -
US 7115262
Chimeric protein for prevention and treatment of HIV infection
granted -
US 7105171
Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
granted -
US 7105156
Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells
granted -
US 7101541
Utilization of non-viral sequences for minus-strand DNA transfer and gene reconstitution
granted -
US 7094598
Development of a preventive vaccine for filovirus infection in primates
granted
Frequently asked questions
How many Infectious disease patents are indexed?
1,492 patents match our Infectious disease classifier (title keywords in USPTO records).
Is this legal or medical advice?
No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.